INTRANASAL BLEEDING


Intranasal bleeding (« epistaxis ») affects close to 10% of worldwide population, i.e. 750 million patients (with 10% requiring medical attention).

0

50%

Current treatments are ineffective in 30 to 50% of the patients.

CAVI-T : A SIGNIFICANT ADVANCEMENT THAT REINVENTS BALLOON TECHNOLOGIES

In the treatment of epistaxis, medical needs are not optimally addressed with current treatment options facing significant failure rates (30% to 50%) and often invasive. To fix this problem, Dianosic has developed and designed an Intranasal asymmetric balloon (CAVI-T), which addresses bleeding challenges while offering structural support post operatively.

 


CAVI-T ASYMMETRIC BALLOON

  • Unique asymmetric design (low-pressure)
  • Optimal conformation to the anatomy
  • Easy to use / repositionable
  • Anterior and posterior bleeding
  • Nasal breathing through a dedicated channel
  • Reduced pain and rebleeding upon removal
  • Click on the PDF for country user manuals

CAVI-T COATED ASYMMETRIC BALLOON

  • Antiinflammatory and antimicrobial properties
  • Infection prevention / healing promotion post surgery
  • Very helpful in patients at risk of infection or anticoagulated

An innovative solution in the management of bleeding and support of intranasal structures. Watch the video to learn more…

Bleeding arrest demonstrated in 90% of patients

Low pain upon removal

Ease of use

Patient comfort : breathing channel

Discreet, low pressure balloon

Quick return to home

Can be removed by a home nurse

Reduced budget impact (hospitals, insurers)

ASYMMETRIC BALLOON PROJECT PROGRESS

POC
PROTOTYPING
CE MARKING
COMMERCIALIZATION

ACTIVE ASYMMETRIC BALLOON PROJECT PROGRESS

POC